Scientific & Policy Comments

NASS’ Health Policy and Research Councils regularly comment on a variety of policy and scientific topics on behalf of members and patients. Comments are frequently submitted to Congress and regulatory agencies, including CMS and the FDA, as well as quality improvement entities.​

Recent comment letters are included below.

Oct 24, 2016


NASS Endorses ECHO Act